The predictive value of ERCC1 was analysed by observing the correlation between OS of the lung adenocarcinoma patients in different TNM stages treated with different therapeutic modalities, and ERCC1 status (Fig. 2a, b). This evidence concerns the gene ERCC1 and lung adenocarcinoma.